What was studied?
A dose-escalation investigation enrolled healthy male volunteers in groups of eight. Researchers measured ipamorelin concentrations and growth hormone, then fitted a pharmacokinetic/pharmacodynamic model to the observed time courses.
What did the researchers report?
Exposure was approximately dose-proportional in the investigated range. A transient growth-hormone response followed exposure, and the model characterized its time course. Between-person variation was larger for response parameters than for exposure parameters.
What are the limits?
A fitted hormone-response model is not a treatment protocol and cannot establish improvements in health or performance. The participants were selected healthy men and observation was short-term. Different formulations and research materials cannot be assumed to reproduce these findings.
Original editorial summary by Sulan Peptide. Based on the source abstract; consult the full paper for methods, analyses, funding and disclosures.